In Brief Zelia Correa named co-director of ocular oncology service at Sylvester and Bascom Palmer Eye Institute February 14, 2020Vol.46 No.07
In Brief Karyn Aalami Goodman named associate director for clinical research at The Tisch Cancer Institute at Mount Sinai February 14, 2020Vol.46 No.07
In Brief Lillian Siu receives TAT 2020 Honorary Award for cancer drug development February 14, 2020Vol.46 No.07
NCI Sharpless addresses three big issues in cancer in 2020:1. NCI grantees are prime targets for foreign influence, 2. Treatment seems to drive drop in lung cancer deaths, 3. RPG paylines to rise from 8% to 10% February 14, 2020Vol.46 No.07By Matthew Bin Han Ong
Drugs & Targets EMA accepts tucatinib application in HER2-positive breast cancer February 07, 2020Vol.46 No.06
Drugs & Targets EMA accepts application for belantamab mafodotin for multiple myeloma February 07, 2020Vol.46 No.06
Drugs & Targets European advisory group backs Pfizer’s Rituxan biosimilar February 07, 2020Vol.46 No.06
Drugs & Targets FDA, FTC collaborate to deter anti-competitive practices involving biosimilars February 07, 2020Vol.46 No.06
